Skip to main content
Fig. 1 | BMC Nephrology

Fig. 1

From: Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy

Fig. 1

Proteinurias change after KunXian treatment (A) and discontinued the treatment (B and C). Panel A shows proteinuria changes from baseline to the first follow-up after KunXian treatment. All but two (96%, green lines) patients showed a reduction in proteinuria at the first follow-up. Panel B shows proteinuria changes of the six patients who discontinued the KX treatment at first follow-up visit. Panel C shows proteinuria changes of the twelve patients who discontinued the KX treatment during the full follow-up. Eleven of the twelve patients (91.7%) showed an increase in proteinuria after discontinued the KX treatment. # This patient discontinued the KX treatment for no improvement of the disease at the first follow-up visit. FU, Follow-up; KX, KunXian

Back to article page